Access cutting-edge lung cancer treatment through this clinical trial at a research site in Elmhurst. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Elmhurst at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
This study, known as LUNAR-2, aims to investigate the effectiveness and safety of using TTFields, delivered by the NovoTTF-200T device, concomitantly administered with pembrolizumab and platinum-based chemotherapy for patients with advanced non-small cell lung cancer that has spread to other parts of the body. The primary goals of the study are to assess overall survival and progression-free survival. Secondary objectives include analyzing outcomes based on the specific histology (subtype) of th
Sponsor: NovoCure GmbH
Check if you qualify for this lung cancer clinical trial in Elmhurst, IL
If you're searching for lung cancer treatment options in Elmhurst, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Elmhurst research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.